Purchase Order N3239825P0120
Award Date
6/3/25
Potential Completion Date
7/30/25
Potential Value
$91K
Federal Agency
Bureau of Medicine and Surgery
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Fort Detrick, MD 21702, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a for-profit manufacturer of genetic analysis instruments and reagents. The $249,894.20 contract is for the delivery of an Illumina MiSeq sequencing system, to be used at the agency's location in Rockville, Maryland. Illumina has provided similar sequencing systems and related supplies to support genomic research and diagnostics at various federal agencies, including...
This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, for the delivery of a MiSeq System sequencer. The award does not have a set-aside designation and has a ceiling value of $95,931. Illumina has a history of providing sequencing systems and related products and services to...
This firm fixed-price delivery order was awarded by the Southeast Area of the U.S. Department of the Navy's Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $95,931 award is for the provision of an Illumina MiSeq System, a high-throughput DNA sequencing platform, to support nucleic acid sequencing needs at the Naval Medical Research Center's Biological Defense Research Directorate. This delivery order is part of a...
This is a firm fixed price purchase order contract awarded by the Naval Sea Systems Command to Illumina, Inc. to provide a MiSeq DNA Sequencer for $111,782.23. The contract has no set-aside designation. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, and has previously provided various sequencing systems, reagents, and services to support research and diagnostics across multiple federal agencies. This award is likely part of Illumina's...
This is a firm fixed price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract, valued at $95,931.00, is for the delivery of a MiSeq System, a DNA sequencing instrument used for genomic research and diagnostics. While Illumina has previously received prime contract and sub-contract awards from other federal agencies such as the NIH, CDC, USDA, and VA to provide a range of its sequencing...
This firm-fixed-price purchase order was awarded by the U.S. Department of the Navy's Bureau of Medicine and Surgery to Illumina, Inc., a for-profit manufacturer of biotechnology and genomic analysis products, for the delivery of one NovaSeq 6000 sequencing system. The $945,107.50 contract will support COVID-19 research at the Naval Medical Research Center in Fort Detrick, Maryland. The contract includes installation and training services. This requirement was a brand name-only solicitation with...
This firm fixed-price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The $116,503.92 contract is for the delivery of undisclosed sequencing products and services to support the agency's mission. Illumina has an Indefinite Delivery Contract worth up to $3.3 million with the Navy for providing reagents and controls for various Illumina sequencing platforms used by the Naval...
This is a $752,450 firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample prep kits, sequencing chips, support plans, maintenance services, and bioinformatics products. This contract...
This is a firm fixed-price purchase order worth $499,633.76 awarded by the Defense Health Agency to Illumina, Inc. for the procurement of a NEXTSEQ 550 SEQUENCING SYSTEM. The contract has no set-aside designation. Illumina has been a long-standing provider of sequencing instruments, reagents, and bioinformatics solutions to various federal agencies, including the NIH, CDC, USDA, and VA, to support genomic research and diagnostics. While this appears to be a standalone purchase order, Illumina...
This firm fixed price delivery order was awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $81,810 contract is for the provision of a MiSeq instrument, with no set-aside designation. Illumina has a history of providing sequencing systems, reagents, and bioinformatics support to various federal agencies for research and diagnostic applications. This order falls under Illumina's $3.3...